Association of Eating Pattern and Nutritional Status with Dyslipidemia Among Adults in Yogyakarta - Indonesia
Abstract
As 35.9 % Indonesian has cholesterol > 200 mg · dL−1 which higher than 2007 (31.9 %). This study is to investigate the association between eating pattern and nutritional status with dyslipidemia. Cross-sectional study and subjects represent the most populated areas in Yogyakarta, taken in Umbulharjo (urban), Turi and Minggir (rural) by cluster sampling. It is used by interview using food consumption pattern, questionnaire,
and measured nutritional status such as body mass index (BMI), waist circumference (WC), body fat mass, and blood serum. The subject is categorized dyslipidemia if total cholesterol (TC), triglyceride (TG) or low-density lipoprotein (LDL) is higher than standard. Prevalence dyslipidemia in urban (55.6 %) was higher than rural (44.4 %). From 385 subjects, 195 (50.6 %) had dyslipidemia and 190 (49.4 %) had normal. BMI, percent body fat, and visceral fat were higher on dyslipidemia than normal (24.30 vs. 23.16, 26.73 % vs. 25.84 %, and 8.42 vs. 6.72; P = 0.02, P = 0.31 and P = 0.001, respectively). WC was higher on dyslipidemia than normal (81.66 cm vs. 77 cm on male and 82.49 cm vs. 79.44 cm on the female; P = 0.005 and P = 0.06). Fatty, grilled and processed food, and instant noodle were associated with dyslipidemia (P ≤ 0.0001). Mean of fruits and vegetable consumption was lower on dyslipidemia than normal (0.59 vs. 0.63) portions· d−1 and (1.57 vs. 1.61) portions · d−1, respectively). BMI, visceral fat, WC on male, and food consumption pattern are associated with dyslipidemia. For prevention risk of dyslipidemia, we should control nutritional status in the normal category, increase the portion of fruit and vegetable and minimize unhealthy food consumption.
Keywords: Adults, Dyslipidemia, Eating pattern, Nutritional status, Yogyakarta.
References
[1] Ministry of Health of Indonesia. Basic health research. Publishing Institutions and Development Agency, 2013.p. 17. [in Bahasa Indonesia] www.depkes.go.id/ resources/download/general/Hasil%20Riskesdas%202013.pdf
[2] Qi L1, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing China. Int. J. Environ. Res. Public Health. 2015;12:13455–13465. https://www.ncbi.nlm.nih.gov/pubmed/26516874
[3] Adams LB. Hyperlipidemia. Guidelines for Adolescent Nutrition Services chapter 10, 2005. p. 109. Available from: http://www.epi.umn.edu/let/pubs/adol_book.shtm
[4] Millen BE, Wolongevicz DM, de Jesus JM, Nonas CA, Lichtenstein AH. 2013 American heart association/American college of cardiology guideline on lifestyle management to reduce cardiovascular risk: Practice opportunities for registered dietitian nutritionist. J. Acad. Nutr. Diet. 2014;114:1723–1729. https://www.ncbi.nlm. nih.gov/pubmed/25439080
[5] Pongchaiyakul C, Hongsprabhas P, Pisprasert V, Pongchaiyakul C. Rural-urban difference in lipid levels and prevalence of dyslipidemia: A population-based study in Khon Kaen Province, Thailand. J Med Assoc Thai. 2006:89(11):1835–1844. https: //www.ncbi.nlm.nih.gov/pubmed/17205863
[6] Raj AS, K Sivakumar, K Sujatha. Prevalence of dyslipidemia in South Indian adults: An urban-rural comparison. Int J Community Med Public Health. 2016:3(8):2201–2210. https://www.researchgate.net/publication/ 305715943_Prevalence_of_dyslipidemia_in_South_Indian_adults_an_urbanrural_ comparison
[7] YR Limbau. Lipid profile of adult Nepalese population. Nepal Med Coll J. 2008:10(1):4–7. https://www.ncbi.nlm.nih.gov/pubmed/18700621
[8] Khader YS. Prevalence of dyslipidemia and its associated factors among Jordanian adults. Journal of Clinical Lipidology. 2010:4:53–58. https://www.ncbi.nlm.nih.gov/ pubmed/21122627
[9] Bansal M, Shrivastava S, Mehrotra R, Agrawal V, Kasliwal RR. Time-trends in prevalence and awereness of cardiovascular risk factors in an asymptomatic North Indian urban population. JAPI. 2009:57:568–73. https://www.ncbi.nlm.nih.gov/ pubmed/20209717
[10] Musunuru K. Atherogenic dyslipidemia: Cardiovascular risk and dietary intervention. Lipids. 2010;45:907–914. https://www.ncbi.nlm.nih.gov/pubmed/20524075
[11] Sartika RAD, Wulandari RA, Ompusunggu IJ, Sutrisna B. Risk factors of dyslipidemia in hypertensive patients in selected urban and rural areas in Indonesia. J Food Nutr Disor. 2015;4(2):1–5. https://www.scitechnol.com/risk-factors-of-dyslipidemiain- hypertensive-patients-in-selected-urban-and-rural-areas-inindonesia-LPjw. php?article_id=2715
[12] Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients. 2013;5:1218–1240. https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3705344/
[13] Brown CD. Body mass index and the prevalence of hypertension and dyslipidemia. Obesity Research. 2000;8:606–619. https://www.ncbi.nlm.nih.gov/pubmed/ 11225709
[14] Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidemia: Comparison of data from two national surveys. Int J Clin Pr. 2007;61:737–747. https://www.ncbi.nlm.nih.gov/pubmed/17493087
[15] Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrient. 2013;5:2708–2733. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738996/
[16] Misra A, Khurana L. Obesity related non-communicable diseases: South Asians vs White Caucasians. Int. J. Obes. 2011;35:167–187. https://www.ncbi.nlm.nih.gov/ pubmed/20644557
[17] Sekhri T, Kanwar RS, Wilfred R, P Chugh, M Chhillar, R Aggarwal, Y K Sharma, et al. Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ. 2014;4:1–8. http://dx.doi.org/10.1136/bmjopen-2014-005346
[18] Doupa D, Seck SM, Dia, CA, Diallo FA, Kane MO, Kane A, Gueye PM, Mbaye MN, et al. Dyslipidemia, obesity and other cardiovascular risk factors in the adult population in Senegal. Pan African Medical Journal. 2014;19:181–188. https://www.ncbi.nlm.nih. gov/pubmed/25815102
[19] Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin PH, Karanja NM et al. Effects on blood lipids of a blood pressure-lowering diet: The dietary approaches to stop hypertension (DASH) trial. Am J Clin Nutr. 2001;74:80–89. https://www.ncbi.nlm. nih.gov/pubmed/11451721
[20] Son JI, Chin SO, Woo JT. Treatment guidelines for dyslipidemia: Summary of the expanded second version. J Lipid Atheroscler. 2012;1(2):45–59. https://doi.org/10. 12997/jla.2012.1.2.45
[21] Cortez-Pinto H, Machado M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Review Gastroenterology Hepatology. 2008;V(2):217–231. https://www.ncbi.nlm.nih.gov/pubmed/19072357
[22] Joshi SR, Anjana RM, Deepa M, Rajendra P, Anil B, Vinay KD, Prashant PJ, et al. Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study. PloS ONE. 2014:9(5):1–9. http://journals.plos.org/plosone/article?id=10.1371/journal.pone. 0096808